Compliance Rate
Compliance Rate
100.0%
Compliant submissions
1
Incompliant submissions
0
Total trials
1
My Organizations' Clinical Trials
Showing 275 of 833 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/19/18
End: 05/23/23
Due: 05/23/24
Phase: N/A
Priority: Normal
Start: 09/30/04
End: 11/30/05
Due: 11/30/06
Phase: N/A
Priority: Normal
Start: 05/31/11
End: 07/31/13
Due: 07/31/14
Phase: N/A
Priority: Normal
Start: 04/30/12
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 04/07/23
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 06/30/11
End: 09/30/18
Due: 09/30/19
Phase: N/A
Priority: Normal
Start: 06/15/15
End: 10/24/17
Due: 10/24/18
Phase: N/A
Priority: Normal
Start: 06/11/25
End: 11/30/27
Due: 11/30/28
Phase: N/A
Priority: Normal
Start: 11/30/09
End: 05/31/16
Due: 05/31/17
Phase: N/A
Priority: Normal
Start: 01/31/15
End: 10/31/16
Due: 10/31/17
Phase: N/A
Priority: Normal
Start: 05/16/22
End: 08/17/24
Due: 08/17/25
Phase: N/A
Priority: Normal
Start: 10/31/06
End: 12/31/13
Due: 12/31/14
Phase: N/A
Priority: Normal
Start: 10/18/16
End: 10/01/18
Due: 10/01/19
Phase: N/A
Priority: Normal
Start: 08/06/20
End: 05/29/22
Due: 05/29/23
Phase: N/A
Priority: Normal
Start: 10/12/18
End: 04/07/23
Due: 04/07/24
Phase: N/A
Priority: Normal
Start: 05/09/19
End: 07/20/23
Due: 07/20/24
Phase: N/A
Priority: Normal
Start: 09/30/98
End: 04/30/99
Due: 04/30/00
Trial Using Motivational Interviewing Positive Affect and Self-Affirmation in Hypertension (TRIUMPH)
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 04/30/14
Due: 04/30/15
Phase: N/A
Priority: Normal
Start: 06/30/25
End: 07/31/26
Due: 07/31/27
Phase: N/A
Priority: Normal
Start: 07/13/21
End: 04/26/23
Due: 04/26/24
Phase: N/A
Priority: Normal
Start: 06/30/25
End: 12/31/31
Due: 12/31/32
Phase: N/A
Priority: Normal
Start: 07/15/20
End: 08/11/22
Due: 08/11/23
Phase: N/A
Priority: Normal
Start: 10/10/17
End: 09/01/23
Due: 09/01/24
Phase: N/A
Priority: Normal
Start: 01/01/16
End: 04/25/18
Due: 04/25/19
Phase: N/A
Priority: Normal
Start: 10/13/20
End: 04/21/22
Due: 04/21/23